Document Detail


Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle.
MedLine Citation:
PMID:  17317376     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study evaluated the effects of beta blockers (carvedilol and metoprolol XL) on New York Heart Association functional class and systemic right ventricular (RV) function in patients with complete transposition of the great arteries who had systemic RV dysfunction late after atrial inflow correction. A significant improvement in New York Heart Association functional class was found after 4 months of therapy with beta blockers. Functional recovery was significant mostly in those patients with pacemakers who received higher maintenance doses of carvedilol. RV end-diastolic area was significantly greater in untreated patients at the end of the follow-up period, whereas it was unchanged in treated patients. In conclusion, beta blockers prevent RV remodeling, with a concomitant improvement in exercise tolerance in patients with complete transposition of the great arteries and systemic RV dysfunction.
Authors:
Abdul Rahman K Doughan; Michael E McConnell; Wendy M Book
Related Documents :
718766 - Noninvasive assessment of left ventricular function in myotonic muscular dystrophy.
20525986 - Galectin-3, cardiac structure and function, and long-term mortality in patients with ac...
9525756 - Evaluation of altered myocardial high energy phosphate metabolism in patients on mainte...
20122556 - Heart failure with preserved versus reduced left ventricular systolic function: a prosp...
7744936 - Medullary lavage reduces embolic phenomena and cardiopulmonary changes during cemented ...
20537496 - An unfavorable dietary pattern is associated with symptomatic ischemic stroke and carot...
Publication Detail:
Type:  Journal Article     Date:  2007-01-08
Journal Detail:
Title:  The American journal of cardiology     Volume:  99     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-02-23     Completed Date:  2007-04-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  704-6     Citation Subset:  AIM; IM    
Affiliation:
Adult Congenital Cardiac Program, Emory University School of Medicine, Atlanta, Georgia, USA. adougha@emory.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use*
Adult
Carbazoles / therapeutic use*
Female
Follow-Up Studies
Humans
Male
Metoprolol / analogs & derivatives*,  therapeutic use
Propanolamines / therapeutic use*
Retrospective Studies
Stroke Volume / physiology
Transposition of Great Vessels / complications*,  physiopathology,  ultrasonography
Treatment Outcome
Ventricular Dysfunction, Right / complications*,  drug therapy*,  physiopathology
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Carbazoles; 0/Propanolamines; 0/metoprolol succinate; 37350-58-6/Metoprolol; 72956-09-3/carvedilol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Determinants of outcome in fetal pulmonary valve stenosis or atresia with intact ventricular septum.
Next Document:  Relation of heart rate recovery after exercise to C-reactive protein and white blood cell count.